BIOMAT Database Logo BIOMAT Database Logo

[The efficacy of using letsedil for treating patients with digestive organ diseases]. 1996

I I Degtiareva, and S Semeunović, and S Petrović, and A V Gaĭsenko, and N V Kharchenko, and I T Egorova

UI MeSH Term Description Entries
D008276 Magnesium Hydroxide An inorganic compound that occurs in nature as the mineral brucite. It acts as an antacid with cathartic effects. Brucite,Magnesium Hydrate,Magnesium Hydroxide (Mg(OH)4),Hydrate, Magnesium,Hydroxide, Magnesium
D002794 Choline A basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. Bursine,Fagine,Vidine,2-Hydroxy-N,N,N-trimethylethanaminium,Choline Bitartrate,Choline Chloride,Choline Citrate,Choline Hydroxide,Choline O-Sulfate,Bitartrate, Choline,Chloride, Choline,Choline O Sulfate,Citrate, Choline,Hydroxide, Choline,O-Sulfate, Choline
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D004066 Digestive System Diseases Diseases in any part of the GASTROINTESTINAL TRACT or the accessory organs (LIVER; BILIARY TRACT; PANCREAS). Digestive System Disorders,Hepatobiliary Diseases,Hepatobiliary Disorders,Digestive System Disease,Digestive System Disorder,Hepatobiliary Disease,Hepatobiliary Disorder,System Disorders, Digestive
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006635 Histamine H2 Antagonists Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. Antihistaminics, H2,H2 Receptor Blockader,Histamine H2 Antagonist,Histamine H2 Blocker,Histamine H2 Receptor Antagonist,Histamine H2 Receptor Antagonists,Histamine H2 Receptor Blockader,Histamine H2 Receptor Blockaders,Antagonists, Histamine H2,Blockaders, Histamine H2 Receptor,H2 Receptor Blockaders,Histamine H2 Blockers,Receptor Antagonists, Histamine H2,Receptor Blockaders, H2,Antagonist, Histamine H2,Blockader, H2 Receptor,Blockaders, H2 Receptor,Blocker, Histamine H2,Blockers, Histamine H2,H2 Antagonist, Histamine,H2 Antagonists, Histamine,H2 Antihistaminics,H2 Blocker, Histamine,H2 Blockers, Histamine,Receptor Blockader, H2
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

I I Degtiareva, and S Semeunović, and S Petrović, and A V Gaĭsenko, and N V Kharchenko, and I T Egorova
[The possibilities of using gastrotsepin in treating digestive organ diseases].
June 1993, Voenno-meditsinskii zhurnal,
I I Degtiareva, and S Semeunović, and S Petrović, and A V Gaĭsenko, and N V Kharchenko, and I T Egorova
[Experience in treating digestive organ diseases with medicinal plants].
March 1989, Vrachebnoe delo,
I I Degtiareva, and S Semeunović, and S Petrović, and A V Gaĭsenko, and N V Kharchenko, and I T Egorova
[Organization of specialized service for patients with digestive organ diseases].
January 1972, Terapevticheskii arkhiv,
I I Degtiareva, and S Semeunović, and S Petrović, and A V Gaĭsenko, and N V Kharchenko, and I T Egorova
[The role of questionnaires in detecting patients with digestive organ diseases].
January 1991, Vrachebnoe delo,
I I Degtiareva, and S Semeunović, and S Petrović, and A V Gaĭsenko, and N V Kharchenko, and I T Egorova
[The importance of esophagoscintigraphy for assessing esophageal function in patients with digestive organ diseases].
June 1990, Vrachebnoe delo,
I I Degtiareva, and S Semeunović, and S Petrović, and A V Gaĭsenko, and N V Kharchenko, and I T Egorova
[Study of digestive organ diseases].
January 1978, Sovetskoe zdravookhranenie,
I I Degtiareva, and S Semeunović, and S Petrović, and A V Gaĭsenko, and N V Kharchenko, and I T Egorova
[Dispensary care of children with digestive organ diseases].
January 1981, Fel'dsher i akusherka,
I I Degtiareva, and S Semeunović, and S Petrović, and A V Gaĭsenko, and N V Kharchenko, and I T Egorova
[Medical economic effectiveness of treating chronic digestive organ diseases in a sanatorium and preventorium].
January 1978, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
I I Degtiareva, and S Semeunović, and S Petrović, and A V Gaĭsenko, and N V Kharchenko, and I T Egorova
[Experience in using a mathematical model for the differential diagnosis of digestive organ diseases].
September 1979, Vrachebnoe delo,
I I Degtiareva, and S Semeunović, and S Petrović, and A V Gaĭsenko, and N V Kharchenko, and I T Egorova
[Phytotherapy in digestive organ diseases].
September 1991, Vrachebnoe delo,
Copied contents to your clipboard!